Search all medical codes

Destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), face, ears, eyelids, nose, lips, mucous membrane; lesion diameter 2.1 to 3.0 cm

CPT4 code

Name of the Procedure:

Destruction of malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement) on the face, ears, eyelids, nose, lips, or mucous membrane; lesion diameter 2.1 to 3.0 cm.

Summary

This procedure involves removing cancerous skin lesions on sensitive areas such as the face, ears, eyelids, nose, lips, or mucous membrane. Different techniques like laser surgery, electrosurgery, cryosurgery, chemosurgery, or surgical curettement are used to destroy the malignant tissue.

Purpose

The procedure is aimed at eliminating cancerous lesions and preventing the spread of skin cancer. It targets malignant growths to maintain cosmetic appearance and functional integrity of the affected areas.

Indications

  • Diagnosed malignant skin lesion between 2.1 cm and 3.0 cm in diameter.
  • Suspicious or confirmed skin cancer requiring removal.
  • Lesions located in cosmetically and functionally important areas (face, ears, eyelids, nose, lips, mucous membranes).

Preparation

  • Patients may need to avoid certain medications such as blood thinners.
  • Fasting may not be required, but following specific pre-procedure instructions by the healthcare provider is crucial.
  • Diagnostic tests like biopsy, imaging, or blood tests may be conducted.

Procedure Description

  1. The area is cleaned and sterilized.
  2. Local anesthesia is applied to numb the area.
  3. Depending on the method chosen:
    • Laser surgery: A focused light beam removes cancerous tissues.
    • Electrosurgery: Electrical currents burn away malignant cells.
    • Cryosurgery: Liquid nitrogen freezes and destroys abnormal cells.
    • Chemosurgery: Chemical agents (e.g., topical creams) target and kill cancer cells.
    • Surgical curettement: A curette (sharp surgical instrument) scrapes off the lesion.
  4. The site may be dressed with a bandage.

Duration

The procedure typically takes 30 minutes to an hour.

Setting

Performed in a hospital, outpatient clinic, or specialized surgical center.

Personnel

  • Dermatologist or oncologic surgeon.
  • Nursing staff.
  • Anesthesiologist, if sedation is used.

Risks and Complications

  • Infection at the site.
  • Scarring or changes in skin pigmentation.
  • Bleeding or bruising.
  • Recurrence of the lesion.

Benefits

  • Effective removal of cancerous tissue.
  • Minimized risk of cancer spreading.
  • Potentially lifesaving.
  • Rapid return to normal activities with minimal downtime.

Recovery

  • Keep the treated area clean and dry.
  • Follow specific wound care instructions.
  • Pain management with prescribed or over-the-counter medications.
  • Avoid strenuous activities until fully healed.
  • A follow-up appointment may be necessary.

Alternatives

  • Mohs Surgery: Highly effective for certain skin cancers but may be more complex.
  • Radiation Therapy: Non-surgical option but involves multiple sessions over time.
  • Systemic Treatments: Such as chemotherapy, for more widespread disease.

Patient Experience

  • Minimal discomfort during the procedure due to local anesthesia.
  • Slight pain, swelling, or redness around the treated area post-procedure.
  • Scarring is possible but often minimal and manageable.
  • Pain relief measures include medications and recommended skin care routines.

Medical Policies and Guidelines for Destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), face, ears, eyelids, nose, lips, mucous membrane; lesion diameter 2.1 to 3.0 cm

Related policies from health plans

Similar Codes